Announcement of the Advisory Panel on Outreach and Education (APOE) February 3, 2022 Virtual Meeting, 2614-2616 [2022-00745]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
2614
Federal Register / Vol. 87, No. 11 / Tuesday, January 18, 2022 / Notices
organizations include Health
Maintenance Organizations (HMOs) and
Competitive Medical Plans (CMPs)
under Section 1876, in addition to,
Health Care Prepayment Plans (HCPPs)
under Section 1833. These entities may
be collectively referred to as Managed
Care Organizations (MCOs). The cost
and statistical data is submitted to CMS
within the cost report, Form CMS 276
(OMB No.0938–0165). CMS is
responsible for the receipt and
processing of Form CMS 276. Form
CMS 276, provided by CMS as excel
worksheets, covers the prescribed
format for the cost reports.
The cost report worksheets are
designed to be of sufficient flexibility to
take into account the diversity of
operations, yet provide the necessary
cost and statistical information to enable
CMS to determine the proper amount of
payment to the Plan. Cost-based MCOs
must submit through HPMS an annual
Budget Forecast, semi-annual interim,
and final cost report to CMS, all of
which are included in this collection.
Additionally, HMOs/CMPs are required
to submit fourth quarter interim reports
annually to CMS; however, the required
submission of 4th quarter interim
reports is waived until further notice by
CMS. Please note that HCPPs are not
required to submit fourth quarter
interim reports. Form Number: CMS–
276 (OMB control number: 0938–0165);
Frequency: Quarterly; Affected Public:
Private Sector Number of Respondents:
17; Number of Responses: 51; Total
Annual Hours: 1,612. (For questions
regarding this collection contact Frank
Cisar at 410–786–7553).
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: The PACE
Organization Application Process in 42
CFR part 460; Use: The Programs of AllInclusive Care for the Elderly (PACE)
consist of pre-paid, capitated plans that
provide comprehensive health care
services to frail, older adults in the
community who are eligible for nursing
home care according to State standards.
PACE organizations (PO) must provide
all Medicare and Medicaid covered
services; financing of this model is
accomplished through prospective
capitation of both Medicare and
Medicaid payments. Upon approval of a
PACE application, CMS executes a
3-way program agreement with the
applicant entity and the applicable State
Administering Agency (SAA). CMS
regulations at 42 CFR 460.98(b)(2)
require a PO to provide PACE services
in at least the PACE center, the home,
and inpatient facilities. The PACE
center is the focal point for the delivery
VerDate Sep<11>2014
17:00 Jan 14, 2022
Jkt 256001
of PACE services; the center is where
the interdisciplinary team (IDT) is
located, services are provided, and
socialization occurs with staff that is
consistent and familiar to participants.
Collection of this information is
mandated by statute under sections
1894(f) and 1934(f) of the Act and at 42
CFR part 460, subpart B, which
addresses the PO application and
waiver process. In general, PACE
services are provided through a PO. An
entity wishing to become a PO must
submit an application to CMS that
describes how the entity meets all the
requirements in the PACE program. An
entity’s application must be
accompanied by an assurance from the
SAA of the State in which the PO
wishes to operate its PACE program.
CMS accepts applications on a
designated date four times per year (i.e.,
on a quarterly basis, generally the last
Friday of March, June, September and
December). Form Number: CMS–10631
(OMB control number: 0938–1326);
Frequency: Occasionally; Affected
Public: Private Sector, State, Local or
Tribal governments, Business or other
for-profits; Number of Respondents: 72;
Total Annual Responses: 130; Total
Annual Hours: 7,271. For policy
questions regarding this collection
contact Debbie Vanhoven at 410–786–
6625.
Dated: January 11, 2022.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2022–00735 Filed 1–14–22; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–7065–N]
Announcement of the Advisory Panel
on Outreach and Education (APOE)
February 3, 2022 Virtual Meeting
Centers for Medicare &
Medicaid Services (CMS), Department
of Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
This notice announces the
next meeting of the APOE (the Panel) in
accordance with the Federal Advisory
Committee Act. The Panel advises and
makes recommendations to the
Secretary of the U.S. Department of
Health and Human Services (HHS) (the
Secretary) and the Administrator of the
Centers for Medicare & Medicaid
SUMMARY:
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Services (CMS) on opportunities to
enhance the effectiveness of consumer
education strategies concerning the
Health Insurance Marketplace®,
Medicare, Medicaid, and the Children’s
Health Insurance Program (CHIP). This
meeting is open to the public.
DATES:
Meeting Date: Thursday, February 3,
2022 from 12:00 p.m. to 5:00 p.m.
eastern standard time (e.s.t).
Deadline for Meeting Registration,
Presentations, Special
Accommodations, and Comments:
Thursday, January 27, 2022 5:00 p.m.
(e.s.t).
ADDRESSES:
Meeting Location: Virtual. All those
who RSVP will receive the link to
attend.
Presentations and Written Comments:
Presentations and written comments
should be submitted to: Lisa Carr,
Designated Federal Official (DFO),
Office of Communications, Centers for
Medicare & Medicaid Services, 200
Independence Avenue SW, Mailstop
325G HHH, Washington, DC 20201,
202–690–5742, or via email at APOE@
cms.hhs.gov.
Registration: Persons wishing to
attend this meeting must register at the
website https://www.eventbrite.com/e/
apoe-february-3-2022-virtual-meetingtickets-212590763697 or by contacting
the DFO listed in the FOR FURTHER
INFORMATION CONTACT section of this
notice, by the date listed in the DATES
section of this notice. Individuals
requiring sign language interpretation or
other special accommodations should
contact the DFO at the address listed in
the ADDRESSES section of this notice by
the date listed in the DATES section of
this notice.
FOR FURTHER INFORMATION CONTACT: Lisa
Carr, Designated Federal Official, Office
of Communications, 200 Independence
Avenue SW, Mailstop 325G HHH,
Washington, DC 20201, 202–690–5742,
or via email at APOE@cms.hhs.gov.
Additional information about the APOE
is available at: https://www.cms.gov/
Regulations-and-Guidance/Guidance/
FACA/APOE. Press inquiries are
handled through the CMS Press Office
at (202) 690–6145.
SUPPLEMENTARY INFORMATION:
I. Background and Charter Renewal
Information
A. Background
The Advisory Panel for Outreach and
Education (APOE) (the Panel) is
governed by the provisions of the
Federal Advisory Committee Act
(FACA) (Pub. L. 92–463), as amended (5
E:\FR\FM\18JAN1.SGM
18JAN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 11 / Tuesday, January 18, 2022 / Notices
U.S.C. Appendix 2), which sets forth
standards for the formation and use of
federal advisory committees. The Panel
is authorized by section 1114(f) of the
Social Security Act (the Act) (42 U.S.C.
1314(f)) and section 222 of the Public
Health Service Act (42 U.S.C. 217a).
The Secretary of the U.S. Department
of Health and Human Services (HHS)
(the Secretary) signed the charter
establishing the Citizen’s Advisory
Panel on Medicare Education 1 (the
predecessor to the APOE) on January 21,
1999 (64 FR 7899) to advise and make
recommendations to the Secretary and
the Administrator of the Centers for
Medicare & Medicaid Services (CMS) on
the effective implementation of national
Medicare education programs, including
with respect to the Medicare+Choice
(M+C) program added by the Balanced
Budget Act of 1997 (Pub. L. 105–33).
The Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA) (Pub. L. 108–173)
expanded the existing health plan
options and benefits available under the
M+C program and renamed it the
Medicare Advantage (MA) program.
CMS has had substantial responsibilities
to provide information to Medicare
beneficiaries about the range of health
plan options available and better tools
to evaluate these options. The
successful MA program implementation
required CMS to consider the views and
policy input from a variety of private
sector constituents and to develop a
broad range of public-private
partnerships.
In addition, Title I of the MMA
authorized the Secretary and the
Administrator of CMS (by delegation) to
establish the Medicare prescription drug
benefit. The drug benefit allows
beneficiaries to obtain qualified
prescription drug coverage. In order to
effectively administer the MA program
and the Medicare prescription drug
benefit, we have substantial
responsibilities to provide information
to Medicare beneficiaries about the
range of health plan options and
benefits available, and to develop better
tools to evaluate these plans and
benefits.
The Patient Protection and Affordable
Care Act (Pub. L. 111–148) and Health
Care and Education Reconciliation Act
of 2010 (Pub. L. 111–152) (collectively
referred to as the Affordable Care Act)
expanded the availability of other
options for health care coverage and
enacted a number of changes to
1 We note that the Citizen’s Advisory Panel on
Medicare Education is also referred to as the
Advisory Panel on Medicare Education (65 FR
4617). The name was updated in the Second
Amended Charter approved on July 24, 2000.
VerDate Sep<11>2014
17:00 Jan 14, 2022
Jkt 256001
Medicare as well as to Medicaid and
CHIP. Qualified individuals and
qualified employers are now able to
purchase private health insurance
coverage through a competitive
marketplace, called an Affordable
Insurance Exchange (also called Health
Insurance Marketplace®, or
Marketplace® 2). In order to effectively
implement and administer these
changes, we must provide information
to consumers, providers, and other
stakeholders through education and
outreach programs regarding how
existing programs will change and the
expanded range of health coverage
options available, including private
health insurance coverage through the
Marketplace®. The APOE (the Panel)
allows us to consider a broad range of
views and information from interested
audiences in connection with this effort
and to identify opportunities to enhance
the effectiveness of education strategies
concerning the Affordable Care Act.
The scope of this Panel also includes
advising on issues pertaining to the
education of providers and stakeholders
with respect to the Affordable Care Act
and certain provisions of the Health
Information Technology for Economic
and Clinical Health (HITECH) Act
enacted as part of the American
Recovery and Reinvestment Act of 2009
(ARRA) (Pub. L. 111–5).
On January 21, 2011, the Panel’s
charter was renewed and the Panel was
renamed the Advisory Panel for
Outreach and Education. The Panel’s
charter was most recently renewed on
January 19, 2021, and will terminate on
January 19, 2023 unless renewed by
appropriate action.
B. Charter Renewal
In accordance with the January 19,
2021, charter, the APOE will advise the
HHS and CMS on developing and
implementing education programs that
support individuals who are enrolled in
or eligible for Medicare, Medicaid,
CHIP, or coverage available through the
Health Insurance Marketplace® and
other CMS programs. The scope of this
FACA group also includes advising on
education of providers and stakeholders
with respect to health care reform and
certain provisions of the HITECH Act
enacted as part of the ARRA.
The charter will terminate on January
19, 2023, unless renewed by appropriate
action. The APOE was chartered under
42 U.S.C. 217a, section 222 of the Public
Health Service Act, as amended. The
APOE is governed by provisions of
2 Health Insurance Marketplace® and
Marketplace® are service marks of the U.S.
Department of Health and Human Services.
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
2615
Public Law 92–463, as amended (5
U.S.C. Appendix 2), which sets forth
standards for the formation and use of
advisory committees.
In accordance with the renewed
charter, the APOE will advise the
Secretary and the CMS Administrator
concerning optimal strategies for the
following:
• Developing and implementing
education and outreach programs for
individuals enrolled in, or eligible for,
Medicare, Medicaid, the CHIP, and
coverage available through the Health
Insurance Marketplace® and other CMS
programs.
• Enhancing the federal government’s
effectiveness in informing Medicare,
Medicaid, CHIP, or the Health Insurance
Marketplace® consumers, issuers,
providers, and stakeholders, pursuant to
education and outreach programs of
issues regarding these programs,
including the appropriate use of publicprivate partnerships to leverage the
resources of the private sector in
educating beneficiaries, providers,
partners and stakeholders.
• Expanding outreach to minority and
underserved communities, including
racial and ethnic minorities, in the
context of Medicare, Medicaid, the CHIP
and the Health Insurance Marketplace®
education programs, and other CMS
programs as designated.
• Assembling and sharing an
information base of ‘‘best practices’’ for
helping consumers evaluate health
coverage options.
• Building and leveraging existing
community infrastructures for
information, counseling, and assistance.
• Drawing the program link between
outreach and education, promoting
consumer understanding of health care
coverage choices, and facilitating
consumer selection/enrollment, which
in turn support the overarching goal of
improved access to quality care,
including prevention services,
envisioned under the Affordable Care
Act.
The current members of the Panel as
of September 15, 2021, are as follows:
• Julie Carter, Senior Federal Policy
Associate, Medicare Rights Center.
• Scott Ferguson, Director of Care
Transitions and Population Health,
Mount Sinai St. Luke’s Hospital.
• Jean-Venable Robertson Goode,
Professor, Department of
Pharmacotherapy and Outcomes
Science, School of Pharmacy, Virginia
Commonwealth University.
• Ted Henson, Director of Health
Center Performance and Innovation,
National Association of Community
Health Centers.
E:\FR\FM\18JAN1.SGM
18JAN1
2616
Federal Register / Vol. 87, No. 11 / Tuesday, January 18, 2022 / Notices
• Joan Ilardo, Director of Research
Initiatives, Michigan State University,
College of Human Medicine.
• Cheri Lattimer, Executive Director,
National Transitions of Care Coalition.
• Cori McMahon, Vice President,
Tridiuum.
• Alan Meade, Director of
Rehabilitation Services, Holston
Medical Group.
• Michael Minor, National Director,
H.O.P.E. HHS Partnership, National
Baptist Convention USA, Incorporated.
• Jina Ragland, Associate State
Director of Advocacy and Outreach,
AARP Nebraska.
• Morgan Reed, Executive Director,
Association for Competitive
Technology.
• Margot Savoy, Senior Vice
President, American Academy of Family
Physicians.
• Congresswoman Allyson Schwartz,
Senior Advisor, FTI Consulting.
• Tia Whitaker, Statewide Director,
Outreach and Enrollment, Pennsylvania
Association of Community Health
Centers.
II. Provisions of This Notice
khammond on DSKJM1Z7X2PROD with NOTICES
In accordance with section 10(a) of
the FACA, this notice announces a
meeting of the APOE. The agenda for
the February 3, 2022 meeting will
include the following:
• Welcome and listening session with
CMS leadership
• Recap of the previous (September 15,
2021) meeting
• CMS programs, initiatives, and
priorities
• An opportunity for public comment
• Meeting summary, review of
recommendations, and next steps
Individuals or organizations that wish
to make a 5-minute oral presentation on
an agenda topic should submit a written
copy of the oral presentation to the DFO
at the address listed in the ADDRESSES
section of this notice by the date listed
in the DATES section of this notice. The
number of oral presentations may be
limited by the time available.
Individuals not wishing to make an oral
presentation may submit written
comments to the DFO at the address
listed in the ADDRESSES section of this
notice by the date listed in the DATES
section of this notice.
III. Meeting Participation
The meeting is open to the public, but
attendance is limited to registered
participants. Persons wishing to attend
this meeting must register at the website
https://www.eventbrite.com/e/apoefebruary-3-2022-virtual-meeting-tickets212590763697 or contact the DFO at the
VerDate Sep<11>2014
17:00 Jan 14, 2022
Jkt 256001
address or number listed in the FOR
section of
this notice by the date specified in the
DATES section of this notice. This
meeting will be held virtually.
Individuals who are not registered in
advance will be unable to attend the
meeting.
FURTHER INFORMATION CONTACT
IV. Collection of Information
This document does not impose
information collection requirements,
that is, reporting, recordkeeping, or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35).
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Chiquita Brooks-LaSure, having
reviewed and approved this document,
authorizes Lynette Wilson, who is the
Federal Register Liaison, to
electronically sign this document for
purposes of publication in the Federal
Register.
Dated: January 11, 2022.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare
& Medicaid Services.
holder informed FDA that it submitted
annual reports for ANDA 075941.
Therefore, FDA rescinds its withdrawal
of approval of ANDA 075941. The
approval of ANDA 075941 is still in
effect.
FOR FURTHER INFORMATION CONTACT:
James Hanratty, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 75, Rm. 1671,
Silver Spring, MD 20993–0002, 240–
402–4718, James.Hanratty@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
Corrections
In the Federal Register of Friday,
October 22, 2021 (86 FR 58675), in FR
Doc. 2021–23075, the following
corrections are made:
1. On page 58675, in the second
column, correct the DATES section to
read: DATES: Approval is withdrawn as
of October 22, 2021.’’
2. On page 58679, in the table, remove
the entry for ANDA 075941.
Dated: January 12, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–00831 Filed 1–14–22; 8:45 am]
BILLING CODE 4164–01–P
[FR Doc. 2022–00745 Filed 1–14–22; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2021–N–1037]
Fresenius USA, Inc., et al.; Withdrawal
of Approval of 216 Abbreviated New
Drug Applications; Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
The Food and Drug
Administration (FDA) is correcting a
notice that appeared in the Federal
Register of October 22, 2021. The
document announced the withdrawal of
approval of 216 abbreviated new drug
applications (ANDAs) from multiple
applicants, as of November 22, 2021.
The document was published with an
incorrect date. In addition, the
document indicated that FDA was
withdrawing approval of ANDA 075941,
Strontium Chloride SR–89 Injection, 1
millicurie/milliliter, held by BioNucleonics, Inc., 1600 Market St., Suite
13200, Philadelphia, PA 19103, for
repeated failure to submit annual
reports. Before FDA withdrew the
approval of this ANDA, the application
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
[Docket No. FDA–2021–P–0885]
Determination That PEPCID
(Famotidine) Tablet, 20 Milligrams and
40 Milligrams, Was Not Withdrawn
From Sale for Reasons of Safety or
Effectiveness
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
SUMMARY:
Food and Drug Administration
Notice.
The Food and Drug
Administration (FDA or Agency) has
determined that PEPCID (famotidine)
tablet, 20 milligrams (mg) and 40 mg,
was not withdrawn from sale for reasons
of safety or effectiveness. This
determination means that FDA will not
begin procedures to withdraw approval
of abbreviated new drug applications
(ANDAs) that refer to this drug product,
and it will allow FDA to continue to
approve ANDAs that refer to the
product as long as they meet relevant
legal and regulatory requirements.
FOR FURTHER INFORMATION CONTACT:
Stacy Kane, Center for Drug Evaluation
and Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 51, Rm. 6236, Silver Spring,
SUMMARY:
E:\FR\FM\18JAN1.SGM
18JAN1
]]>Agencies
[Federal Register Volume 87, Number 11 (Tuesday, January 18, 2022)]
[Notices]
[Pages 2614-2616]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00745]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-7065-N]
Announcement of the Advisory Panel on Outreach and Education
(APOE) February 3, 2022 Virtual Meeting
AGENCY: Centers for Medicare & Medicaid Services (CMS), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the next meeting of the APOE (the Panel)
in accordance with the Federal Advisory Committee Act. The Panel
advises and makes recommendations to the Secretary of the U.S.
Department of Health and Human Services (HHS) (the Secretary) and the
Administrator of the Centers for Medicare & Medicaid Services (CMS) on
opportunities to enhance the effectiveness of consumer education
strategies concerning the Health Insurance Marketplace[supreg],
Medicare, Medicaid, and the Children's Health Insurance Program (CHIP).
This meeting is open to the public.
DATES:
Meeting Date: Thursday, February 3, 2022 from 12:00 p.m. to 5:00
p.m. eastern standard time (e.s.t).
Deadline for Meeting Registration, Presentations, Special
Accommodations, and Comments: Thursday, January 27, 2022 5:00 p.m.
(e.s.t).
ADDRESSES:
Meeting Location: Virtual. All those who RSVP will receive the link
to attend.
Presentations and Written Comments: Presentations and written
comments should be submitted to: Lisa Carr, Designated Federal Official
(DFO), Office of Communications, Centers for Medicare & Medicaid
Services, 200 Independence Avenue SW, Mailstop 325G HHH, Washington, DC
20201, 202-690-5742, or via email at [email protected].
Registration: Persons wishing to attend this meeting must register
at the website https://www.eventbrite.com/e/apoe-february-3-2022-virtual-meeting-tickets-212590763697 or by contacting the DFO listed in
the FOR FURTHER INFORMATION CONTACT section of this notice, by the date
listed in the DATES section of this notice. Individuals requiring sign
language interpretation or other special accommodations should contact
the DFO at the address listed in the ADDRESSES section of this notice
by the date listed in the DATES section of this notice.
FOR FURTHER INFORMATION CONTACT: Lisa Carr, Designated Federal
Official, Office of Communications, 200 Independence Avenue SW,
Mailstop 325G HHH, Washington, DC 20201, 202-690-5742, or via email at
[email protected]. Additional information about the APOE is available
at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE.
Press inquiries are handled through the CMS Press Office at (202) 690-
6145.
SUPPLEMENTARY INFORMATION:
I. Background and Charter Renewal Information
A. Background
The Advisory Panel for Outreach and Education (APOE) (the Panel) is
governed by the provisions of the Federal Advisory Committee Act (FACA)
(Pub. L. 92-463), as amended (5
[[Page 2615]]
U.S.C. Appendix 2), which sets forth standards for the formation and
use of federal advisory committees. The Panel is authorized by section
1114(f) of the Social Security Act (the Act) (42 U.S.C. 1314(f)) and
section 222 of the Public Health Service Act (42 U.S.C. 217a).
The Secretary of the U.S. Department of Health and Human Services
(HHS) (the Secretary) signed the charter establishing the Citizen's
Advisory Panel on Medicare Education \1\ (the predecessor to the APOE)
on January 21, 1999 (64 FR 7899) to advise and make recommendations to
the Secretary and the Administrator of the Centers for Medicare &
Medicaid Services (CMS) on the effective implementation of national
Medicare education programs, including with respect to the
Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997
(Pub. L. 105-33).
---------------------------------------------------------------------------
\1\ We note that the Citizen's Advisory Panel on Medicare
Education is also referred to as the Advisory Panel on Medicare
Education (65 FR 4617). The name was updated in the Second Amended
Charter approved on July 24, 2000.
---------------------------------------------------------------------------
The Medicare Prescription Drug, Improvement, and Modernization Act
of 2003 (MMA) (Pub. L. 108-173) expanded the existing health plan
options and benefits available under the M+C program and renamed it the
Medicare Advantage (MA) program. CMS has had substantial
responsibilities to provide information to Medicare beneficiaries about
the range of health plan options available and better tools to evaluate
these options. The successful MA program implementation required CMS to
consider the views and policy input from a variety of private sector
constituents and to develop a broad range of public-private
partnerships.
In addition, Title I of the MMA authorized the Secretary and the
Administrator of CMS (by delegation) to establish the Medicare
prescription drug benefit. The drug benefit allows beneficiaries to
obtain qualified prescription drug coverage. In order to effectively
administer the MA program and the Medicare prescription drug benefit,
we have substantial responsibilities to provide information to Medicare
beneficiaries about the range of health plan options and benefits
available, and to develop better tools to evaluate these plans and
benefits.
The Patient Protection and Affordable Care Act (Pub. L. 111-148)
and Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-
152) (collectively referred to as the Affordable Care Act) expanded the
availability of other options for health care coverage and enacted a
number of changes to Medicare as well as to Medicaid and CHIP.
Qualified individuals and qualified employers are now able to purchase
private health insurance coverage through a competitive marketplace,
called an Affordable Insurance Exchange (also called Health Insurance
Marketplace[supreg], or Marketplace[supreg] \2\). In order to
effectively implement and administer these changes, we must provide
information to consumers, providers, and other stakeholders through
education and outreach programs regarding how existing programs will
change and the expanded range of health coverage options available,
including private health insurance coverage through the
Marketplace[supreg]. The APOE (the Panel) allows us to consider a broad
range of views and information from interested audiences in connection
with this effort and to identify opportunities to enhance the
effectiveness of education strategies concerning the Affordable Care
Act.
---------------------------------------------------------------------------
\2\ Health Insurance Marketplace[supreg] and Marketplace[supreg]
are service marks of the U.S. Department of Health and Human
Services.
---------------------------------------------------------------------------
The scope of this Panel also includes advising on issues pertaining
to the education of providers and stakeholders with respect to the
Affordable Care Act and certain provisions of the Health Information
Technology for Economic and Clinical Health (HITECH) Act enacted as
part of the American Recovery and Reinvestment Act of 2009 (ARRA) (Pub.
L. 111-5).
On January 21, 2011, the Panel's charter was renewed and the Panel
was renamed the Advisory Panel for Outreach and Education. The Panel's
charter was most recently renewed on January 19, 2021, and will
terminate on January 19, 2023 unless renewed by appropriate action.
B. Charter Renewal
In accordance with the January 19, 2021, charter, the APOE will
advise the HHS and CMS on developing and implementing education
programs that support individuals who are enrolled in or eligible for
Medicare, Medicaid, CHIP, or coverage available through the Health
Insurance Marketplace[supreg] and other CMS programs. The scope of this
FACA group also includes advising on education of providers and
stakeholders with respect to health care reform and certain provisions
of the HITECH Act enacted as part of the ARRA.
The charter will terminate on January 19, 2023, unless renewed by
appropriate action. The APOE was chartered under 42 U.S.C. 217a,
section 222 of the Public Health Service Act, as amended. The APOE is
governed by provisions of Public Law 92-463, as amended (5 U.S.C.
Appendix 2), which sets forth standards for the formation and use of
advisory committees.
In accordance with the renewed charter, the APOE will advise the
Secretary and the CMS Administrator concerning optimal strategies for
the following:
Developing and implementing education and outreach
programs for individuals enrolled in, or eligible for, Medicare,
Medicaid, the CHIP, and coverage available through the Health Insurance
Marketplace[supreg] and other CMS programs.
Enhancing the federal government's effectiveness in
informing Medicare, Medicaid, CHIP, or the Health Insurance
Marketplace[supreg] consumers, issuers, providers, and stakeholders,
pursuant to education and outreach programs of issues regarding these
programs, including the appropriate use of public-private partnerships
to leverage the resources of the private sector in educating
beneficiaries, providers, partners and stakeholders.
Expanding outreach to minority and underserved
communities, including racial and ethnic minorities, in the context of
Medicare, Medicaid, the CHIP and the Health Insurance
Marketplace[supreg] education programs, and other CMS programs as
designated.
Assembling and sharing an information base of ``best
practices'' for helping consumers evaluate health coverage options.
Building and leveraging existing community infrastructures
for information, counseling, and assistance.
Drawing the program link between outreach and education,
promoting consumer understanding of health care coverage choices, and
facilitating consumer selection/enrollment, which in turn support the
overarching goal of improved access to quality care, including
prevention services, envisioned under the Affordable Care Act.
The current members of the Panel as of September 15, 2021, are as
follows:
Julie Carter, Senior Federal Policy Associate, Medicare
Rights Center.
Scott Ferguson, Director of Care Transitions and
Population Health, Mount Sinai St. Luke's Hospital.
Jean-Venable Robertson Goode, Professor, Department of
Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia
Commonwealth University.
Ted Henson, Director of Health Center Performance and
Innovation, National Association of Community Health Centers.
[[Page 2616]]
Joan Ilardo, Director of Research Initiatives, Michigan
State University, College of Human Medicine.
Cheri Lattimer, Executive Director, National Transitions
of Care Coalition.
Cori McMahon, Vice President, Tridiuum.
Alan Meade, Director of Rehabilitation Services, Holston
Medical Group.
Michael Minor, National Director, H.O.P.E. HHS
Partnership, National Baptist Convention USA, Incorporated.
Jina Ragland, Associate State Director of Advocacy and
Outreach, AARP Nebraska.
Morgan Reed, Executive Director, Association for
Competitive Technology.
Margot Savoy, Senior Vice President, American Academy of
Family Physicians.
Congresswoman Allyson Schwartz, Senior Advisor, FTI
Consulting.
Tia Whitaker, Statewide Director, Outreach and Enrollment,
Pennsylvania Association of Community Health Centers.
II. Provisions of This Notice
In accordance with section 10(a) of the FACA, this notice announces
a meeting of the APOE. The agenda for the February 3, 2022 meeting will
include the following:
Welcome and listening session with CMS leadership
Recap of the previous (September 15, 2021) meeting
CMS programs, initiatives, and priorities
An opportunity for public comment
Meeting summary, review of recommendations, and next steps
Individuals or organizations that wish to make a 5-minute oral
presentation on an agenda topic should submit a written copy of the
oral presentation to the DFO at the address listed in the ADDRESSES
section of this notice by the date listed in the DATES section of this
notice. The number of oral presentations may be limited by the time
available. Individuals not wishing to make an oral presentation may
submit written comments to the DFO at the address listed in the
ADDRESSES section of this notice by the date listed in the DATES
section of this notice.
III. Meeting Participation
The meeting is open to the public, but attendance is limited to
registered participants. Persons wishing to attend this meeting must
register at the website https://www.eventbrite.com/e/apoe-february-3-2022-virtual-meeting-tickets-212590763697 or contact the DFO at the
address or number listed in the FOR FURTHER INFORMATION CONTACT section
of this notice by the date specified in the DATES section of this
notice. This meeting will be held virtually. Individuals who are not
registered in advance will be unable to attend the meeting.
IV. Collection of Information
This document does not impose information collection requirements,
that is, reporting, recordkeeping, or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. Chapter 35).
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Chiquita Brooks-LaSure, having reviewed and approved this
document, authorizes Lynette Wilson, who is the Federal Register
Liaison, to electronically sign this document for purposes of
publication in the Federal Register.
Dated: January 11, 2022.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2022-00745 Filed 1-14-22; 8:45 am]
BILLING CODE 4120-01-P
